Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar Defects
Preliminary Clinical Application Study of Saline Infusion Onohysterography in Structure of Cesarean Scar Surgery
1 other identifier
observational
300
1 country
1
Brief Summary
This study selected patients who underwent cesarean section and were scheduled to undergo Saline Infusion Sonohysterography (SIS) for evaluating the structure of the incision. Clinical characteristics and clinical symptoms were collected. Combined with hysteroscopy, MRI, conventional ultrasound and SIS examination results, the study analyzed the detection rate of cesarean section diverticula by SIS, the changes in diverticulum size and the diagnostic efficacy of residual muscle layer thickness at the incision site. The surgical methods and clinical symptom improvement of patients with CSD after surgery were followed up for half a year to one year. The study aimed to clarify the guiding value of SIS in clinical decision-making and patient prognosis for patients, and to analyze the etiological relationship between the true incidence of CSD and clinical complications. Thus, it provided evidence-based basis for clinical events of cesarean section surgery → CSD → CSD complications → surgical treatment of CSD → patient prognosis, promoting the progress of precise diagnosis and treatment of female reproductive health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 18, 2026
CompletedFirst Posted
Study publicly available on registry
May 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
May 28, 2026
May 1, 2026
3.5 years
May 18, 2026
May 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The detection rate of cesarean scar diverticulum
The detection rate of cesarean scar diverticulum refers to the proportion of patients in whom the diverticulum is identified through various diagnostic modalities among all patients examined.
Day 1
Clinical Pregnancy Rate
The clinical pregnancy rate is defined as the proportion of patients with the presence of at least one intrauterine gestational sac with a visible fetal heartbeat, confirmed by transvaginal ultrasound.
Up to 90 days of gestation
Residual myometrial thickness
The Residual myometrial thickness refers to the thickness of the myometrial layer at the uterine lower segment at the site of prior cesarean delivery.
Day 1
Study Arms (1)
This group of patients received appropriate treatment based on the presence or absence of diverticul
The treatment plan was determined by the attending physician according to clinical guidelines and was strictly independent of this observational study protocol.
Interventions
This group of patients received conventional infertility treatment only, without undergoing diverticulum reconstruction surgery, in accordance with standard clinical practice.
Eligibility Criteria
The research population comprised adult women with a prior cesarean delivery who presented to Tangdu Hospital with symptoms including abnormal uterine bleeding, dysmenorrhea, prolonged menstrual spotting, or secondary infertility.
You may qualify if:
- More than 6 months after cesarean delivery;
- Presenting with clinical symptoms-including abnormal uterine bleeding, dysmenorrhea, prolonged menstrual spotting, or secondary infertility;
- Requiring saline infusion sonohysterography (SIS) to evaluate the cesarean scar.
You may not qualify if:
- Multiple cesarean deliveries;
- Patients contraindicated for saline infusion sonohysterography (SIS), including pregnancy or suspected pregnancy, failure to meet vaginal hygiene criteria, inability to cooperate during the procedure, or suboptimal image quality;
- Cases with incomplete clinical data or lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
Tang-Du Hospital
Xi'an, Shaanxi, 710038, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Li Zhang, MD
The Second Affiliated Hospital of Air Force Military Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chief Physician
Study Record Dates
First Submitted
May 18, 2026
First Posted
May 28, 2026
Study Start
January 1, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
May 28, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Data will be available beginning 6 months and ending 36 months following article publication.
- Access Criteria
- To gain access, data requestors will need to contact the corresponding author and sign a formal data access agreement.
De-identified individual participant data (IPD) underlying the results reported in the published article will be shared. Data will be available to researchers who provide a methodologically sound proposal, purely for the purpose of achieving the aims in the approved proposal.